MassBio & Pepper Hamilton Present: Biotechnology Entrepreneurship Boot Camp
Friday, December 6 2013
8:00 am – 6:30 pm
Location: MassBio, 300 Technology Square, 8th floor, Cambridge
This event has reached capacity. Please contact firstname.lastname@example.org with any questions or registration requests.
The one day bootcamp has been created in response to the growing need in the scientific and academic community to learn the necessary skills to transform technology and innovation into a viable company. Through this program we hope to fill the knowledge gap for first time entrepreneurs. The insight and energy required for entrepreneurial success can be developed by anyone motivated to think strategically, select projects and plans for expeditious and cost effective management, understand the requirements of all the involved stakeholders, and oversee the essential components of the fund raising and commercialization process
8:00 pm - 8:30 pm: Registration & Networking
8:30 am - 8:45 am: Opening Remarks
8:45 am - 9:45 am: Assessment and qualifications of technologies as basis for startup - Is it the right time? right technology?
Forming a company around a technology is relatively easy. Staffing and capitalizing it is another story. Savvy employees, Astute venture capitalists and selective prospective strategic partners know that companies without technological "critical mass" sufficient to bring a series of product to the market are unsustainable. This session will provide tools and a contextual framework as to how technologies can be assessed for capitalization and partnering.
- Arthur Hiller, former CEO at SciFluor
- Kevin Bitterman, Principal at Polaris Ventures
- Monique Yoakim-Turk, Ph.D , Associate director of the tech development fund at Boston Children’s Hospital
- Moderator: Steve London, Partner at Pepper Hamilton
9:45 am - 10:15 am: Building the right team
Team building in biotechnology companies is the most challenging task for entrepreneurs, and the backbone of the VC's decision to invest or not to invest. The session provides exploration of issues in forming an entrepreneurial team of start up or early stage company and approaches to successful team formation and management of the team.
- Yael Schwartz, PH President of Restorgenex
- Rudi Scheiber Hurtz, Next Stage Solutions
- George Naumov, Boston Harbor Angels
- Moderator: Greg Williams
10:30am - 11:30am: Developing an effective IP strategy
The goal of this session is to provide information and insight into the specific issues confronting investigators, entrepreneurs, investors and their patent attorneys. The panelists will discuss the importance of developing and maintaining an IP strategy essential for the short and long term goals of the startup. Additionally, the speakers will describe the implications of current IP law versus implications of the America Invents Act. What should you be concerned about, what should you do and when to develop a solid IP strategy.
- John Delyani, Director of strategic alliances at NIBR
- Imran Nasrullah, head of strategic alliances at T1D Exchange
- Moderator: Tom Engellenner, Partner at Pepper Hamilton
11:30 am - 1:00 pm: Buffet lunch
1:00 pm - 2:00 pm: Fireside chat (successful startup story)
2:15 pm - 3:00 pm: Regulatory/Reimbursement
This session will provide the specific insight into planning for FDA regulations in light of strategy, financial needs, and the concerns of prospective partners and investors. It is never too early to assess how the market will respond to products, especially as it relates to pricing and reimbursement. This session will address the fundamentals of pharmaceutical pricing and reimbursement strategies.
- Edward Berger, Principal at Larchmont Advisors
- Greg Dombal, COO at Halloran Consulting
- Maria Buckley, general counsel at Joslin Diabetes Center
- Charles Mathews, Vice President, Boston Healthcare Associates
- Moderator: Lana Gladstein, Partner at Pepper Hamilton
3:00 pm - 3:30 pm: Business plan and pitch deck basics
Experienced entrepreneurs and their investors recognize that within year of operating, few companies resemble their original business plan. Business plans and accompanying pitch however provide the starting point of a shared vision and evidence that the founding team can reach consensus in the business and technology development planning process and the resources required to meet critical milestones. The session provides a framework for developing a pitch and the essentials of a business plan.
3:30 pm - 4:30 pm: Fundraising process vs. licensing , strategic alliances and partnering.
Industry leaders and key thought leaders will identify difference between a pitch for fundraising and partnering.
- Sridaran Natesan, VP of External innovation
- Boris Batchvarov, Boston Harbor angels
- Kees Been, CEO at Lysosomal Therapeutics Inc.
- Tom Luby, Sr. Director of New ventures at J&J Innovation Center Boston
- Moderator: Reza Mollaaghababa, Partner at Pepper Hamilton
4:30 pm - 5:00 pm: Summary & conclusion
- Jeff Libson, Pepper Hamilton
- John Hallinan, MassBio
5:00 pm - 6:30 pm: Cocktail Reception